Quality of life (QOL) in patients with multiple sclerosis (MS) is influenced by disease progression and the level of disability, as well as individ......READ MORE
As the probability of active multiple sclerosis (MS) declines with age and the susceptibility to adverse effects increases, the risks vs the benefi......READ MORE
Magnetic resonance imaging (MRI) remains the standard for assessment and monitoring in multiple sclerosis (MS). Recent developments in brain imagin......READ MORE
An increased understanding of the pathophysiology of multiple sclerosis (MS) has led to the development and recent US Food and Drug Administration ......READ MORE
by Robert A. Bermel, MD, MBA; Malcolm H. Gottesman, MD; and Eric C. Klawiter, MD, MSc
Advancements in basic science and successful clinical trials have provided the foundation for the rapid expansion of treatment options for multiple......READ MORE
by Robert A. Bermel, MD, MBA; Malcolm H. Gottesman, MD; and Eric C. Klawiter, MD, MSc
From B-cell–depleting monoclonal antibodies to sphingosine-1-phosphate receptor modulators, the diversity of the available high-potency therapies i......READ MORE
